Fig 1.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of study selection.
Table 1.
Characteristics of the studies included in the meta-analysis (n = 5).
Fig 2.
Pooled mean differences for the outcomes of diastolic blood pressure changes in patients with hypertension receiving rosuvastatin therapy vs. placebo or standard care.
Fig 3.
Pooled mean differences for the outcomes of changes in systolic blood pressure in patients with hypertension receiving rosuvastatin therapy vs. placebo or standard care.
Fig 4.
Funnel plot for outcomes of changes in diastolic blood pressure.
Fig 5.
Funnel plot for outcomes of changes in systolic blood pressure.
Fig 6.
Pooled mean differences for the outcomes of diastolic blood pressure changes in patients with hypertension treated with a combination of rosuvastatin and one antihypertensive agent.
Fig 7.
Pooled mean differences for the outcomes of systolic blood pressure changes in patients with hypertension treated with a combination of rosuvastatin and one antihypertensive agent.
Fig 8.
Pooled mean differences for the outcomes of diastolic blood pressure changes in patients with hypertension treated with a triple combination of rosuvastatin plus two antihypertensive agents.
Fig 9.
Pooled mean differences for the outcomes of systolic blood pressure changes in patients with hypertension treated with a triple combination of rosuvastatin plus two antihypertensive agents.
Fig 10.
Risk of bias.